Last reviewed · How we verify
NCT04893720
The SPINUS II Study: Spinal Fusion for Multilevel SPECT/CT Positive Lumbar Degeneration
trial testing Lumbar fusion in Degenerative Disc Disease in 30 participants. Currently enrolling.
1 June 2025
Quick facts
| Lead sponsor | Military University Hospital, Prague |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 1 June 2021 |
| Primary completion | 1 June 2025 |
| Estimated completion | 1 June 2026 |
| Sites | 2 locations across Czechia |
Drugs / interventions tested
- Lumbar fusion
Conditions studied
- Degenerative Disc Disease — all drugs for Degenerative Disc Disease →
- Back Pain Lower Back Chronic — all drugs for Back Pain Lower Back Chronic →
- Facet Joint Arthropathy — all drugs for Facet Joint Arthropathy →
- Facet Syndrome of Lumbar Spine — all drugs for Facet Syndrome of Lumbar Spine →
Sponsor
Military University Hospital, Prague
Who can join
Adults 18 to 75, any sex, with Degenerative Disc Disease or Back Pain Lower Back Chronic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present study is to find out whether fusion of multilevel SPECT/CT positive lumbar degeneration leads to a significant improvement of pain and disability.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04893720
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lumbar fusion
Trials testing the same drug.
- NCT04408846 — Minimally Invasive Surgery Versus Traditional Open Surgery In The Treatment Of Single Level Lumbar Stenosis · NA · withdrawn
- NCT04876586 — The SPINUS I Study: Spinal Fusion for a Single Level SPECT/CT Positive Lumbar Degenerative Disc Disease · completed
Other recruiting trials for Degenerative Disc Disease
Currently open trials in the same condition.
- NCT07254806 — A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to · Phase 3 · recruiting
- NCT04679844 — Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Au · NA · recruiting
- NCT06704919 — Conduit Cages and Fibergraft BG Putty · recruiting
- NCT06053242 — Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Ba · Phase 1, PHASE2 · recruiting
- NCT03810573 — Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis · NA · recruiting
Other Military University Hospital, Prague trials
Trials by the same sponsor.
- NCT07424963 — Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HE · NA · recruiting
- NCT06519448 — Reducing Non-Alcoholic Steatohepatitis · NA · enrolling by invitation
- NCT05781347 — Stretta Versus Conservative Treatment · NA · recruiting
- NCT05929365 — Innovative Approach to Detect Recurrent Colorectal Lesions With Surveillance Via Mutation Analysis & Clinical Phenotype · recruiting
- NCT04434053 — Adjustable Gravitational vs. Adjustable Differential Pressure Valves in iNPH · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04893720 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Military University Hospital, Prague
- Last refreshed: 13 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04893720.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing